PT - JOURNAL ARTICLE AU - Challen, Robert AU - Tsaneva-Atanasova, Krasimira AU - Pitt, Martin AU - Edwards, Tom AU - Gompels, Luke AU - Lacasa, Lucas AU - Brooks-Pollock, Ellen AU - Martin, Chris AU - Griffith, Gareth AU - Danon, Leon TI - Estimates of regional infectivity of COVID-19 in the United Kingdom following imposition of social distancing measures AID - 10.1101/2020.04.13.20062760 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.13.20062760 4099 - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20062760.short 4100 - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20062760.full AB - We describe regional variation in the reproduction number of SARS-CoV-2 infections observed using publicly reported data in the UK, with a view to understanding both if there are clear hot spots in viral spread in the country, or other spatial patterns. Based on case data up to the 9th April, we estimate that the viral replication number remains above 1 overall in the UK but that its trend is to decrease. This suggests the peak of the first wave of COVID-19 patients is imminent. We find that there is significant regional variation in the UK and that this is changing over time. Within England currently the reproductive ratio is lowest in the Midlands (1.11 95% CI 1.07; 1.14), and highest in the North East of England (1.38 95% CI 1.33-1.42). There are long and variable time delays between infection and detection of cases, and thus it remains unclear whether the reduction in the reproductive number is a result of social distancing measures. If we are to prevent further outbreaks, it is critical that we both reduce the time taken for detection and improve our ability to predict the regional spread of outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRCh and KTA gratefully acknowledges the financial support of the EPSRC via grant EP/N014391/1 and NHS England, Global Digital Exemplar programme. LD and KTA gratefully acknowledges the financial support of The Alan Turing Institute under the EPSRC grant EP/N510129/1. LL acknowledges the financial support of the EPSRC via Early Career Fellowship EP/P01660X/Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is public domain and accessible through GitHub https://github.com/terminological/uk-covid-datatools/blob/master/vignettes/Supplementary_Rt_Timeseries_by_Unitary_Authority.csv?raw=true https://docs.google.com/spreadsheets/d/1snb-vYuH7fVpTuyoQrM8zWiABYoXbSrnn44w-zlhM90/edit?usp=sharing